Journal Article

Access to bacteriophage therapy: discouraging experiences from the human cell and tissue legal framework

G. Verbeken, I. Huys, D. De Vos, A. De Coninck, D. Roseeuw, E. Kets, A. Vanderkelen, J. P. Draye, T. Rose, S. Jennes, C. Ceulemans and J. P. Pirnay

Edited by Andrew Millard

in FEMS Microbiology Letters

Published on behalf of Federation of European Microbiological Societies

Volume 363, issue 4 Published in print February 2016 | ISSN: 0378-1097
Published online December 2015 | e-ISSN: 1574-6968 | DOI: https://dx.doi.org/10.1093/femsle/fnv241

More Like This

Show all results sharing these subjects:

  • Medical Microbiology and Virology
  • Biotechnology
  • Genetics and Genomics
  • Microbiology
  • Molecular and Cell Biology

GO

Show Summary Details

Preview

Graphical Abstract Figure.

Therapeutic natural bacteriophages should not be classified under the medicinal product regulatory frames as they exist today.

Keywords: bacteriophage therapy; keratinocytes; regulatory; Advanced Therapy Medicinal Products; biological medicinal products; hospital exemption

Journal Article.  3533 words.  Illustrated.

Subjects: Medical Microbiology and Virology ; Biotechnology ; Genetics and Genomics ; Microbiology ; Molecular and Cell Biology

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or purchase to access all content.